AiimSense
AiimSense is a Canadian medical device startup that has developed BrainScreen™, a portable, AI-enabled electromagnetic brain scanner for real-time stroke and traumatic brain injury detection at the point of care, targeting hospitals, EMS, rural clinics, and military or disaster response settings.
- Company typePrivate
- Founded2019
- HeadquartersKitchener, Canada
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What AiimSense does
AiimSense Inc. is a Canadian privately held medical device company founded in 2019 and headquartered in Waterloo, Ontario, with a secondary office in Calgary, Alberta. The company has 11–50 employees and operates as a pre-commercial startup. Its sole product is BrainScreen™, a lightweight, portable brain scanner that combines electromagnetic imaging (EMI) — using safe, low-power radiation to detect real-time changes in brain dielectric properties — with proprietary AI algorithms to identify strokes (ischemic and hemorrhagic) and traumatic brain injuries at the point of care. The device is designed to deliver diagnostic insight in minutes and to operate in settings where CT and MRI are unavailable, impractical, or too slow.
The company targets healthcare institutions directly, with primary customer segments spanning emergency departments (ER/ICU), pre-hospital EMS/ambulance services, rural and underserved communities, and secondary use in military and disaster response settings. Distribution is conducted via direct institutional B2B sales, and AiimSense is actively pursuing clinical trials, regulatory pathways, and commercialization partnerships. Specific pricing is not publicly disclosed; enterprise medical device pricing is typically custom and configuration-dependent.
AiimSense maintains research collaborations with the University of Waterloo (founding institution), McMaster University, and the University of Toronto, providing engineering and clinical expertise. The company markets itself primarily through its website, LinkedIn, and X (Twitter), and routes investor and partnership inquiries through dedicated email channels ([email protected], [email protected]). It was accepted into the WeSEED cohort on 2025-05-06, though no associated capital amount has been disclosed.
AiimSense firmographics
Firmographics- Name
- AiimSense
- Legal name
- AiimSense Inc.
- Website
- https://aiimsense.com
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- AiimSense is a Canadian medical device startup that has developed BrainScreen™, a portable, AI-enabled electromagnetic brain scanner for real-time stroke and traumatic brain injury detection at the point of care, targeting hospitals, EMS, rural clinics, and military or disaster response settings.
- Ownership category
- akta.pro rank
AiimSense industry classification
Industry- Product category
- Portable Medical Imaging Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables) (HLAHACAE)
- akta.pro secondary industries
- Medical Imaging AI (HDAAAEAH), Biosensors & Lab-on-Chip (BioMEMS) (HDAHALAK)
Keywords
Where AiimSense is headquartered
LocationHeadquarters
- HQ city
- Kitchener
- HQ country
- Canada
- HQ region
- North America
Offices2 records
Markets served
AiimSense business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Supply Chain, Marketing or Sales
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
AiimSense product offering
Product offeringCore offering
AiimSense develops and manufactures BrainScreen™, a lightweight, portable brain scanner that combines electromagnetic imaging (EMI) with proprietary AI algorithms to detect real-time changes in brain dielectric properties. The device is designed for rapid identification of ischemic and hemorrhagic strokes as well as traumatic brain injuries at the point of care — at the bedside, in ambulances, or in remote clinics — replacing or supplementing time-consuming CT and MRI workflows.
Product overview
AiimSense offers a single unified product—the BrainScreen™ portable brain scanner—which combines electromagnetic imaging technology with AI to provide real-time, bedside brain imaging for rapid stroke and traumatic brain injury detection. The system is designed for use across emergency departments, ambulances, rural communities, and military/disaster response settings, delivering actionable diagnostic insights in minutes rather than the time required by traditional CT or MRI systems.
Differentiator
Problem solved
Functional benefit
Brands
- BrainScreen™: Portable brain scanner device combining electromagnetic imaging with advanced AI to detect strokes (ischemic and hemorrhagic) and traumatic brain injuries.
Products and services
- BrainScreen™ Portable Brain Scanner BrainScreen™ is a lightweight, portable brain scanner that combines electromagnetic imaging with proprietary AI algorithms to detect real-time changes in brain dielectric properties. It is designed for rapid identification of ischemic and hemorrhagic strokes as well as traumatic brain injuries, enabling actionable diagnostic insight in minutes at the bedside, in ambulances, or in remote clinics. It is targeted at healthcare institutions including hospitals, emergency departments, EMS providers, and military/disaster response units.
Quantifiable outcome
- Faster triage compared to traditional CT/MRI imaging systems
- +1 more outcomes
Companies that use AiimSense
Customer profileSegments4 records
Ideal customer profiles4 records
AiimSense technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability3 records
Feature3 records
AiimSense partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and secondary.
- University of WaterloocoreAiimSense collaborates with the University of Waterloo as a founding institution. The company was founded at Waterloo and maintains ongoing research collaboration with the university's engineering and science departments.
- McMaster UniversitysecondaryAiimSense collaborates with McMaster University as part of its network of leading research institutions for technology development and clinical research.
- University of TorontosecondaryAiimSense collaborates with the University of Toronto as part of its multidisciplinary team integrating academic expertise, engineering innovation, and clinical insight.
Scale indicators1 record
Recent moves5 records
Expansion highlights6 records
AiimSense competitors and assessment
Company assessmentDirect peers
- NovaSignal Corporation: Commercial-stage company offering portable, AI-enabled transcranial Doppler ultrasound (NovaGuide / Robocath) for real-time cerebral blood flow assessment in stroke and TBI — directly comparable in the portable brain-monitoring category and clinical use case.
- Hyperfine: Public medtech company (NASDAQ: HYPR) commercializing the Swoop™, a portable, low-field MRI system designed for point-of-care brain imaging at the bedside — directly comparable in portable brain imaging mission, though using a different (MRI) modality.
- EMVision Medical Devices: Australian-listed company developing portable, non-ionizing electromagnetic/microwave imaging devices for rapid stroke and TBI detection at the bedside — closest direct technology analog to AiimSense's BrainScreen™ in target use case, modality, and form factor.
- Infrascan (Infrascanner): Company marketing the Infrascanner, a portable, FDA-cleared near-infrared device for rapid detection of intracranial hematomas in TBI — directly comparable as a portable, non-invasive, point-of-care brain diagnostic targeting similar clinical settings including EMS and military.
Broad incumbents
- Stryker (Neurovascular): Major neurovascular incumbent offering stroke intervention products (e.g., Trevo, AXS Catalyst) sold into the same hospital and stroke-center customers that AiimSense targets — comparable as a broad incumbent with established hospital sales channels.
- GE HealthCare: Global imaging incumbent (CT, MRI, PET) that dominates the brain imaging category AiimSense aims to disrupt at the bedside — comparable as the incumbent whose installed base and clinical workflow integration AiimSense must compete against.
- Philips Healthcare: Major imaging OEM (CT, MRI, IntelliVue patient monitoring) serving the same hospital neurology and stroke workflows — comparable as a broad incumbent with deep hospital sales coverage.
- Siemens Healthineers: Global imaging OEM (CT, MRI including MAGNETOM and SOMATOM lines) competing in the brain imaging space — comparable as a broad incumbent that could itself enter portable/AI-enabled brain imaging.
- Medtronic (Neurovascular): Global leader in neurovascular intervention (stent retrievers, aspiration catheters, stroke intervention devices) — comparable as a broad incumbent operating across the stroke care continuum, including adjacent diagnostic and therapeutic products used by the same clinical customers.
Emerging players
- Ceribell: Commercial-stage company offering portable, AI-enabled EEG (Point-of-Care EEG, Clarity Algorithm) for rapid neurological assessment in hospital and EMS settings — comparable as an emerging player in portable, AI-driven brain diagnostics targeting overlapping ED/ICU and pre-hospital customers.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights5 records
Customer concentration
AiimSense social profiles
Digital presenceAiimSense financial estimates
Financial estimateRevenue estimate
Valuation estimate
AiimSense leadership team
Management profileNumber of profiles
AiimSense funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
AiimSense M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about AiimSense
What does AiimSense do?
AiimSense develops and manufactures BrainScreen™, a lightweight, portable brain scanner that combines electromagnetic imaging (EMI) with proprietary AI algorithms to detect real-time changes in brain dielectric properties. The device is designed for rapid identification of ischemic and hemorrhagic strokes as well as traumatic brain injuries at the point of care — at the bedside, in ambulances, or in remote clinics — replacing or supplementing time-consuming CT and MRI workflows.
Is AiimSense a public or private company?
AiimSense is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was AiimSense founded?
AiimSense was founded in 2019. It employs 11 to 50 people.
Where is AiimSense based?
AiimSense is headquartered in Kitchener, Canada, in the North America region.
Who are AiimSense's main competitors?
Direct peers on record are NovaSignal Corporation, Hyperfine, EMVision Medical Devices and Infrascan (Infrascanner). Broad incumbents are Stryker (Neurovascular), GE HealthCare, Philips Healthcare, Siemens Healthineers and Medtronic (Neurovascular). Ceribell is listed as an emerging player.
Does AiimSense have an API?
No public API is recorded for AiimSense.
What industry is AiimSense in?
AiimSense's product category is Portable Medical Imaging Devices. Its primary akta.pro industry code is HLAHACAE, Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables), with a secondary code of HDAAAEAH, Medical Imaging AI. Its NAICS code is 334510 and its SIC code is 3845.